Home » Topics » Briefs » Other news to note

Other news to note
RSS

BTG acquires PneumRx

Jan. 12, 2015

Shire to acquire NPS Pharmaceuticals

Jan. 12, 2015

Cardio3 BioSciences acquires Celdara Medical's OnCyte immuno-oncology cell therapy business

Jan. 12, 2015

Advanced Accelerator Applications acquires Atreus and starts phase I/II trial of imaging agent

Jan. 9, 2015

Stemline Therapeutics licenses novel reversible inhibitor of XPO1 from CanBas

Jan. 9, 2015

Nestle invests in microbiome therapeutics firm Seres Health

Jan. 9, 2015

Gilead Sciences acquires Phenex Pharmaceuticals' FXR liver disease programs

Jan. 8, 2015

Pfizer's acquires Redvax

Jan. 8, 2015

Knight Therapeutics forms product commercialization partnership with NeurAxon

Jan. 5, 2015

Roche to acquire Dutalys

Dec. 23, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...